{"url_path":"/sec/neup/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1191070/0001193125-26-225442-index.html","accession_number":"0001193125-26-225442","cik":"0001191070","ticker":"NEUP","issuer_name":"Neuphoria Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1191070/0001193125-26-225442-index.html","primary_entity_key":"0001191070","primary_entity_name":"Neuphoria Therapeutics Inc."},"word_count":62,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\nFrom time to time, we may become involved in litigation or other legal proceedings relating to claims that we consider to be arising from the ordinary course of our business. There are currently no claims or actions pending against us that, in the opinion of our management, are likely to have a material adverse effect on our business."}